https://www.selleckchem.com/products/apatinib.html
Adherers experienced significantly greater improvements in peak oxygen consumption (29%), strength (7%-18%), mobility (16%), fatigue symptoms (-36%), and QOL (17%-22%) compared with nonadherers (P less then .05). Conclusions Following the PAGs for at least 12 of 16 weeks results in improvements in fitness, mobility, fatigue symptoms, and QOL, confirming their effectiveness for improving health in people with MS. © 2020 Consortium of Multiple Sclerosis Centers.Background Pain is a common and often debilitating symptom in persons with mu
Like
Comment
Share
